
Xintópica 1.5 mg | 3 mg | 6 mg | 12 mg
Antipruritic. Control of Atopic Dermatitis and Pruritus Associated with Allergic Dermatitis in Dogs.

Each chewable tablet contains:
Xintopic ® 1.5 mg: Oclacitinib (as Oclacitinib maleate) 1.5 mg.
Xintopic ® 3 mg: Oclacitinib (as Oclacitinib maleate) 3 mg.
Xintopic ® 6 mg: Oclacitinib (as Oclacitinib maleate) 6 mg.
Xintopic ® 12 mg: Oclacitinib (as Oclacitinib maleate) 12 mg.
Treatment of acute and chronic canine pruritus associated with allergic dermatitis, clinical manifestations of atopic dermatitis.
Oral route. An initial dose of 0.4 to 0.6 mg/kg, twice daily for 14 days.
SENASA Registry: F.115.031.N.00011.
Petmedica® is a division of Agrovet Market S.A.
This content is an informational reference and should not be considered as
recommendation of use.